secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2024-07-02T23:59:59+00:00
Accession:  0001683168-24-004601
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Majority shareholder approves up to 60-for-1 reverse stock split
----------------------------------------------------------------

- Dr. Steve Slilaty, holding 84.8% voting power, approved reverse split by written consent.
- Reverse split ratio up to 60-for-1 of common stock.
- Effective 20 days after mailing definitive information statement to shareholders.
- Dr. Slilaty is CEO and controls majority voting power.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824004601/0001683168-24-004601-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824004601/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-004601

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer